16-3728423-T-G
Variant summary
Our verdict is Benign. Variant got -19 ACMG points: 1P and 20B. PP2BP4_StrongBP6_Very_StrongBS1BS2
The NM_004380.3(CREBBP):c.6624A>C(p.Gln2208His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00164 in 1,612,542 control chromosomes in the GnomAD database, including 6 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_004380.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -19 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CREBBP | NM_004380.3 | c.6624A>C | p.Gln2208His | missense_variant | Exon 31 of 31 | ENST00000262367.10 | NP_004371.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CREBBP | ENST00000262367.10 | c.6624A>C | p.Gln2208His | missense_variant | Exon 31 of 31 | 1 | NM_004380.3 | ENSP00000262367.5 | ||
CREBBP | ENST00000382070.7 | c.6510A>C | p.Gln2170His | missense_variant | Exon 30 of 30 | 1 | ENSP00000371502.3 |
Frequencies
GnomAD3 genomes AF: 0.00177 AC: 269AN: 151940Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.00187 AC: 459AN: 245788Hom.: 3 AF XY: 0.00176 AC XY: 235AN XY: 133484
GnomAD4 exome AF: 0.00163 AC: 2378AN: 1460484Hom.: 5 Cov.: 33 AF XY: 0.00157 AC XY: 1138AN XY: 726536
GnomAD4 genome AF: 0.00177 AC: 269AN: 152058Hom.: 1 Cov.: 32 AF XY: 0.00199 AC XY: 148AN XY: 74368
ClinVar
Submissions by phenotype
not provided Benign:4
CREBBP: BS1 -
This variant is associated with the following publications: (PMID: 16021471, 25659731) -
- -
- -
not specified Benign:2
- -
- -
Inborn genetic diseases Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Rubinstein-Taybi syndrome Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at